Brit. med. Y., 1964, 1, 728-732 The role of antibiotics in bronchitis has been the subject of two previous double-blind investigations by this committee, carried out by a large number of chest physicians throughout urban and rural areas of England, Wales, and Scotland. In the first trial (British Tuberculosis Association, 1960) Association, 1961 ) was more elaborate and set out to compare the effectiveness of the daily antibiotic regimens of the first trial with alternative regimens consisting of intermittent high-dose medication with these same antibiotics at the onset of respiratory symptoms. The result of this trial showed a superiority of the daily tetracycline regimen (four days lost owing to bronchitis as against eight or nine in the other three groups). It was thought that the intermittent regimens might have been associated with fewer days off work if patients had carried out the instructions more effectively. Daily tetracycline was the only regimen associated with a significant fall in the isolation rate of Haemophilus infiuenzae from sputum specimens examined in mid-trial, whereas pneumococcus isolations fell in all four regimens. It was concluded that since daily tetracycline medication had been as effective as daily penicillin in the first trial, and clearly more effective in the second, then it should be considered the drug of choice, an opinion strongly supported by the significant reduction in H. influenzae isolations. It was thought, however, that further investigation should be undertaken especially in view of the high cost of tetracycline. The price of tetracycline has since been reduced.
Present Investigation
The experiment was designed to compare the effectiveness of a number of therapeutic substances when administered twice daily throughout the winter as in the first trial, omitting any form of intermittent treatment but incorporating the same bacteriological study as the second trial. Once more the doubleblind technique was employed, but ethical considerations prevented the inclusion of a control group.
Materials and Methods
The following daily regimens were employed: (May and May, 1963) and of earlier observations (May, 1958) (Biometrika Tables 1958, Table 26 , P=0.01). However, this compound was consistently the worst in each month of the trial, as can be seen in Table III , which shows the days lost from bronchitis and pneumonia by months.
In addition, the number of antibiotic treatments received by patients from their general practitioners was greater on this regain than on any other (Table IV) . 
Side-effects
The main side-effects reported were mild gastro-intestinal symptoms such as nausea and frequent motions occasionally amounting to diarrhoea. There were a few other complaints May and May, 1963) . Tables X and XI show the isolation rates at each stage of the trial of H. influenzae and pneumococci in the six treatment groups. Tetracycline was the only drug associated with a statistically significant fall in the prevalence of H. influenzae in the middle of the trial; the customary relapses of infection, however, occurred after the end of the trial, as indicated by the rise in isolation rates. In contrast, pneumococci were significantly reduced in number by all drugs except sulphamethoxypyridazine, but their behaviour differed from that of their counterparts in the trial of in that, after treatment was stopped, their numbers tended to return to the pretreatment figures. This trend was apparent in each treatment group and is most unusual for this organism. 13/70 (19) 18/67 (27) Note.-(1) The denominator of each fraction indicates the number of patients in the group; the numerator is the number from whom H. influenzae was isolated. Percentages are in parentheses. (2) Differences between isolation rates at the beginning and middle of the trial were significant only in the two tetracycline groups (regimens 3 and 5) (P= between 0 01 and 0-001 in both groups). (22) Note.
- (1) The denominator of each fraction indicates the number of patients in the group; the numerator is the number from whom pneumococci were isolated. Percentages are in parentheses. (2) Difference between isolation rates at the beginning and middle of the trial were significant in all groups except that receiving sulphamethoxypyridazine (regimen 2). (P=0 001, 0 001, 0 02, 0 01, 0-001 respectively.)
No significant change in the sensitivity of H. influenzae to any of the drugs was detected, but it was disturbing to find six strains of pneumococcus resistant to more than 5 jug. of erythromycin per ml. at the end of the trial. Five of these were isolated in patients who received erythromycin and sulphamethoxypyridazine. The sixth came from a patient given tetracycline. This was surprising, since crossed resistance between tetracycline and erythromycin is said not to occur.
Discussion
The main clinical finding of the present trial is the inferiority of sulphamethoxypyridazine in relation to the other five regimens. There may, however, be smaller differences between the latter which are concealed by the variability of response. The similar efficacy of tetracycline and the other antibiotic regimens suggested that pneumococci were important pathogens during the period of this trial.
We are indebted to Mr. H. R. Simpson, of the statistics department, Rothamsted Experimental Station, for his help in the analysis of this trial on the electronic computer there. We are grateful to Joyce White, Barbara Bavester, and Brenda Moore for secretarial assistance, and to Doreen Delves, Beryl Godden, and Alan Schneider for technical help.
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The names of the participating chest physicians are given below, together with the clinics and hospitals at which the investigation was carried out.
In recent years it has been more widely appreciated that even a mild degree of maternal hypoxia in labour may have an adverse effect on the foetus: this is especially true in cases where placental insufficiency may be suspected. It has long been the practice to discontinue gas and air analgesia during labour if any signs of foetal distress appear, because the mother's 0, tension while breathing "gs and air " is lowered. Cole and Nainby-Luxmore (1962) drew attention to the decreased arterial C) saturation found in labouring women receiving gas and air analgesia. They also found considerable variation in the amount of 02 delivered by apparently well-maintained gas and air machines in the Oxford area.
The Central Midwives Board (1963b) are reviewing their policy with regard to the administration of inhalational analgesics by midwives, with particular reference to the possible approval of N,,O and 02 apparatuses for use by midwives on their own responsibility.
The Central Midwives Board (1963a) have been reliably informed that the administration of a fixed mixture of 50% N20 and 50%02, provided it is delivered from an adequately tested and calibrated machine, is safe for unsupervised use by midwives, gives efficient analgesia, and may be substituted, where practical, for gas and air analgesia ; also that there is no significant differ-
